Conference Coverage
February 10, 2025
BOREAS Trial: Navtemadlin Demonstrates Clinical Benefit in JAK Inhibitor–Refractory Myelofibrosis
2024 ASH Annual Meeting
February 10, 2025
In Case You Missed It: Additional Studies of Interest From ASH 2024
2024 ASH Annual Meeting
February 10, 2025
Novel Menin Inhibitors Show Safety and Activity in Several Clinical Trials
2024 ASH Annual Meeting
February 06, 2025
Pediatric Stroke Survivors Show Higher Mental Health Risks
American Stroke Association International Stroke Conference 2025
February 03, 2025
Beta Blocker May Shield Women From Migraine-Linked Strokes
American Stroke Association International Stroke Conference 2025
January 30, 2025
Oral Bacteria Linked to Higher Stroke Risk
American Stroke Association International Stroke Conference 2025
January 28, 2025
FDA Approves Enhertu for Metastatic, HR-Positive, HER2-Low or -Ultralow Breast Cancer
2024 ASCO Annual Meeting
January 28, 2025
Anatomic Lung Resection May Be Linked to Improved Survival in Early-Stage NSCLC
2025 STS Annual Meeting
January 28, 2025
Medicare Study Compares LVRS, EBV Outcomes
2025 Society of Thoracic Surgeons (STS) Annual Meeting
January 28, 2025
Surgeon Preference Reframes CABG Arterial Grafting Outcomes
2025 Society of Thoracic Surgeons (STS) Annual Meeting
January 27, 2025
New Research Explores Blood Test to Determine Prognosis, Benefit of Celecoxib in Stage III Colon Cancer
2025 ASCO GI
January 27, 2025
Mortality Decreases With Mechanical AVRs Under 60
2025 Society of Thoracic Surgeons (STS) Annual Meeting
January 23, 2025
Managing Comorbidities in Oncology: Practical Strategies for Optimized Patient Care
2024 JADPRO Live
January 23, 2025
Adjuvant Tamoxifen Reduces 15-Year Risk of Recurrence in ‘Good Risk’ DCIS Without Radiation Therapy
2024 SABCS
January 23, 2025
Some Patients With Low-Risk Ductal Carcinoma In Situ May Be Able to Avoid Surgery
2024 SABCS
January 23, 2025
OlympiA Trial: Long-Term Benefits of Olaparib Confirmed in High-Risk Subgroup of Breast Cancer
2024 SABCS
January 21, 2025
Does a New Blood-Based Screening Test Accurately Detect Colorectal Cancer Risk?
2025 ASCO Gastrointestinal Cancers Symposium
January 21, 2025
ChatGPT Has Limitations in Clinical Utility for Colorectal Cancer but May Be Useful for Patient Education
2025 ASCO Gastrointestinal Cancers Symposium
January 21, 2025
Everolimus/Lanreotide vs Everolimus in Gastroenteropancreatic Neuroendocrine Tumors
2025 ASCO Gastrointestinal Cancers Symposium
January 14, 2025
ADRIATIC Trial: Durvalumab Consolidation Extends Survival in Limited-Stage Small Cell Lung Cancer
ESMO Congress 2024
January 01, 2025
Daratumumab Induction Regimen in Transplant-Ineligible Patients Newly Diagnosed with Multiple Myeloma
2024 International Myeloma Society Annual Meeting
December 09, 2024
Understanding the Assessment and Treatment of High-Risk Myelofibrosis
2024 JADPRO Live
December 09, 2024
Adding Chemoradiation in Perioperative Gastric Cancer Treatment Improves Pathologic Response Rates Without Survival Benefit
ESMO Congress 2024
December 09, 2024
Updated Findings in Preventive Breast Cancer Vaccine Study
2024 SITC Annual Meeting
December 09, 2024
Study Evaluating Lung Cancer Screening Program Receives Margulis Award for Scientific Excellence
RSNA 2024 Annual Meeting
December 09, 2024
4-Year Asian Subpopulation Data From the CheckMate 816 Trial of Neoadjuvant Nivolumab Plus Chemotherapy in Resectable NSCLC
IASLC 2024 Asia Conference on Lung Cancer
December 09, 2024
AI and the Future of Lung Cancer Screening: Still Room for Improvement
Quantitative Imaging Workshop XXI
December 06, 2024
Self-Pay, AI-Based Program May Help Boost Mammogram Findings
RSNA 2024 Annual Meeting
December 05, 2024
Transgender Violence Revealed Through Medical Data
Radiological Society of North America
December 05, 2024
SITC: Study Finds IO102-IO103 Vaccine Plus Pembrolizumab Active in Patients With Non–Small Cell Lung Cancer
2024 SITC Annual Meeting
November 24, 2024
TROPION-Lung01 Update: Dato-DXd Shows Activity in Previously Treated Advanced Nonsquamous NSCLC
2024 IASLC WCLC
November 24, 2024
Use of Aumolertinib Extends Progression-Free Survival in Stage III EGFR-Mutated NSCLC
2024 IASLC WCLC
November 24, 2024
Impact of Food Insecurity on the Incidence of Hepatocellular Carcinoma
2024 AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved
November 24, 2024
Exploring Issues in Oncofertility
FDA-ASCO Virtual Workshop: Measuring Toxicity in Reproductive Organs During Oncology Drug Development
November 24, 2024
Determining the Optimal First-Line Management of Advanced Classical Hodgkin Lymphoma
2024 NCCN Annual Congress: Hematologic Malignancies
November 19, 2024
Wide Variation in SGLT2i Use Across U.S. Hospitals
American Heart Association's Scientific Sessions 2024
November 19, 2024
Four-Year Asian Subpopulation Data From the CheckMate 816 Trial of Neoadjuvant Nivolumab Plus Chemotherapy in Resectable NSCLC
IASLC 2024 Asia Conference on Lung Cancer
November 19, 2024
Determining the Optimal First-Line Management of Advanced Classical Hodgkin Lymphoma
2024 NCCN Annual Congress: Hematologic Malignancies
November 15, 2024
U.S. Obesity May Hit 80% by 2050
American Heart Association’s Hypertension Scientific Sessions 2024
November 14, 2024
AI-Powered Camera Detects Hypertension, Diabetes
American Heart Association's Scientific Sessions 2024
November 14, 2024
Exploring Issues in Oncofertility
FDA-ASCO Virtual Workshop: Measuring Toxicity in Reproductive Organs During Oncology Drug Development
November 14, 2024
From Gaps to Bridges: Cancer Care Rooted in Equity, Quality, and Value
2024 World Cancer Congress
November 12, 2024
Cholesterol Swings: New Dementia Warning Sign
American Heart Association's Scientific Sessions 2024
November 08, 2024
Advancing Diversity, Equity, and Inclusion Through a Challenging Policy Landscape
NCCN Oncology Policy Summit
November 08, 2024
When Cancer and Cardiovascular Disease Intersect
2024 Global Cardio-Oncology Summit
November 08, 2024
Evolving Role of MRD Status in Multiple Myeloma
2024 International Myeloma Society Annual Meeting
November 07, 2024
When Cancer and Cardiovascular Disease Intersect
2024 Global Cardio-Oncology Summit
November 07, 2024
Artificial Livers to Grow on Space Station
American College of Surgeons Clinical Congress
November 01, 2024
Life-threatening eye signs and symptoms to keep on your radar
American Academy of Optometry annual meeting
November 01, 2024
Visual field defect testing can be life saving
American Academy of Optometry annual meeting
November 01, 2024
Facilitating dry eye disease management
American Academy of Optometry annual meeting
October 30, 2024
Acalabrutinib Plus Chemoimmunotherapy Improves Progression-Free Survival in Older Patients With Mantle Cell Lymphoma
European Hematology Association 2024 Congress
October 30, 2024
Glofitamab Combination Therapy Shows Survival Benefit in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
European Hematology Association 2024 Congress
October 30, 2024
Early Signs of Kidney Transplant Rejection Found
American Society of Nephrology (ASN) Kidney Week 2024
October 30, 2024
Diabetes Drug Benefits Fade Without Ongoing Use
American Society of Nephrology (ASN) Kidney Week 2024
October 30, 2024
Adaptable Implant Improves Cleared Heart Arteries
Transcatheter Cardiovascular Therapeutics (TCT) Conference
October 29, 2024
Early AKI Intervention Fails to Improve Outcomes
American Society of Nephrology (ASN) Kidney Week 2024
October 28, 2024
Scientists Develop a ‘Digital Twin’ Model to Predict Cancer Treatment Responses
36th EORTC-NCI-AACR Symposium
October 28, 2024
Early Results Show Novel Agent Has Clinical Activity in FGFR3-Driven Advanced Bladder Cancer
36th EORTC-NCI-AACR Symposium
October 24, 2024
New Hope for Patients With HER2-Mutant NSCLC: Durable Responses to Two Novel Targeted Therapies
2024 IASLC WCLC
October 23, 2024
Anesthesia Inequities Affect Black Patients, Doctors Report
American Society of Anesthesiologists
October 22, 2024
ACA May Increase Access to Colorectal Cancer Care Among Underserved Groups
2024 AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved
October 22, 2024
Survey Describes Factors that Affect Patient Non-Adherence to nAMD Treatment
Euretina 2024
October 21, 2024
ACS Program May Reduce Postsurgical Mortality, Improve Care Among Older Patients
ACS Clinical Congress 2024
October 21, 2024
Cancer Diagnoses May Be Linked to Lasting Financial Challenges
ACS Clinical Congress 2024
October 17, 2024
Advancing Diversity, Equity, and Inclusion Through a Challenging Policy Landscape
NCCN Oncology Policy Summit
October 14, 2024
Euretina 2024: Voretigene Neparvovec-rzyl Therapy Long-Term Functional and Anatomical Outcomes
Euretina 2024
October 14, 2024
p300 KAT Inhibitors Offer Potential Approach for Inflammatory and Autoimmune Conditions
ACR Convergence 2024
October 09, 2024
Creating a Culture of Diversity, Equity, and Inclusion: Why It Matters Clinically and Ethically
NCCN Oncology Policy Summit
October 09, 2024
Study Finds Nearly $70 Billion in Socioeconomic Losses Across 11 Countries Attributable to Ovarian Cancer
2024 World Cancer Congress
October 07, 2024
Euretina 2024: Faricimab Shows Greater Hard Exudate Reduction Compared with Aflibercept
24th Euretina Congress
October 07, 2024
Euretina 2024: Aflibercept Showed Efficacy and Safety vs Laser Therapy in Retinopathy of Prematurity
24th Euretina Congress
October 03, 2024
Duration of Postmastectomy Radiation Therapy in Patients Planning Breast Reconstruction
2024 ASTRO Annual Meeting
October 02, 2024
Immunotherapy/Chemoradiotherapy for Patients With Limited-Stage Small Cell Lung Cancer
2024 ASTRO Annual Meeting
October 02, 2024
Intensity-Modulated Radiation Therapy and Proton-Beam Therapy May Offer Equally High Quality of Life and Tumor Control in Patients With Localized Prostate Cancer
2024 ASTRO Annual Meeting
October 01, 2024
Regeneron Leaders Recognized for Innovation at Eyecelerator 2024
American Academy of Ophthalmology annual meeting
October 01, 2024
Hot Topics for the Comprehensive Ophthalmologist
American Academy of Ophthalmology annual meeting
October 01, 2024
Pharmaceutical Industry Sponsors and Clinical Cancer Research in the United States
2024 ASCO Quality Care Symposium
September 30, 2024
Conversations Between Physicians and Older Patients About Physical Activity May Reduce Falls During Cancer Treatment
2024 ASCO Quality Care Symposium
September 27, 2024
Cisplatin Shortage Led to Treatment Alternatives for Head and Neck Cancer, Significantly Increasing Cost
2024 ASCO Quality Care Symposium
September 24, 2024
Phase III ALEXANDRA/IMpassion030: No Survival Benefit for Adjuvant Atezolizumab in Triple-Negative Breast Cancer
2024 European Breast Cancer Conference
September 24, 2024
Black Patients With Triple-Negative Breast Cancer May Be Less Likely to Receive Immunotherapy Compared With White Patients
2024 AACR Conference on the Science of Cancer Health Disparities in Racial/Ethnic Minorities and the Medically Underserved
September 20, 2024
Phase III CABINET Trial: Cabozantinib in Advanced Neuroendocrine Tumors
ESMO Congress 2024
September 19, 2024
Virtual Reality Treatment for Amblyopia Shows Clinically Meaningful Vision Improvement
Association for Research in Vision and Ophthalmology annual meeting
September 19, 2024
Breastfeeding Safe After Breast Cancer: Studies
European Society for Medical Oncology Breast Cancer Annual Congress 2024
September 18, 2024
Could Sulthiame Offer a New Drug Treatment for Sleep Apnea?
European Respiratory Society (ERS) Congress
September 17, 2024
Study Finds Nearly $70 Billion in Socioeconomic Losses Across 11 Countries Attributable to Ovarian Cancer
2024 World Cancer Congress
September 17, 2024
Trauma Exposure Linked to Accelerated Brain Aging, Alzheimer's Risk
2024 Annual Meeting of The Menopause Society
September 17, 2024
Early Smoking Increases Respiratory Risks by Age 28
European Respiratory Society (ERS) Congress
September 17, 2024
Can Saline Drops Cut Kids' Colds Short?
European Respiratory Society (ERS) Congress
September 13, 2024
Hot Flashes at Night: Timing Matters
2024 Annual Meeting of The Menopause Society
September 09, 2024
Bariatric Surgery Outperformed Meds for Hypertension Control
American Heart Association’s Hypertension Scientific Sessions 2024
September 09, 2024
What Is the Better Target for Bispecific Antibodies in Multiple Myeloma: BCMA or GPRC5D?
2024 Debates and Didactics in Hematology and Oncology
September 09, 2024
EASD: Monthly Semaglutide Injection Shows Promise
European Association for the Study of Diabetes Annual Meeting 2024
September 09, 2024
EASD: Childhood Diet Linked to Type 1 Diabetes Risk
European Association for the Study of Diabetes Annual Meeting 2024
September 04, 2024
Use of Immune Checkpoint Inhibitors Under Study in High-Risk, Hormone Receptor–Positive, Early-Stage Breast Cancer
2024 Miami Breast Cancer Conference
September 01, 2024
An Update on SLT Clinical Trials
American Academy of Ophthalmology annual meeting
August 29, 2024
What Is the Better Target for Bispecific Antibodies in Multiple Myeloma: BCMA or GPRC5D?
2024 Debates and Didactics in Hematology and Oncology
August 26, 2024
BTK Degraders and CELMoDs: Novel Mechanisms Overcoming Resistance in Hematologic Malignancies
2024 Pan Pacific Lymphoma Conference
August 26, 2024
LIBRETTO-431 Trial Shows Selpercatinib Is Effective in East Asian Patients With RET Fusion–Positive Non–Small Cell Lung Cancer
2024 ASCO Breakthrough
August 22, 2024
BTK Degraders and CELMoDs: Novel Mechanisms Overcoming Resistance in Hematologic Malignancies
2024 Pan Pacific Lymphoma Conference
August 13, 2024
Discontinuation of CML Therapy: Which Patients Are Ideal Candidates?
2024 Debates and Didactics in Hematology and Oncology
August 09, 2024
Gestational Diabetes and Risk for Breast Cancer
European Association for the Study of Diabetes Annual Meeting 2024
August 08, 2024
Extranodal Marginal Zone Lymphoma: Is Overtreatment Common?
2024 Pan Pacific Lymphoma Conference
August 06, 2024
Red Meat Tied to Higher Dementia Risk
Alzheimer’s Association International Conference (AAIC) 2024
August 06, 2024
New Study Links Wildfire Smoke to Increased Dementia Risk
Alzheimer’s Association International Conference (AAIC) 2024
August 06, 2024
Active Surveillance May Enable Patients With Esophageal Cancer to Delay or Avoid Surgery
2024 ASCO Breakthrough
August 06, 2024
Radiation Alone May Be as Effective as Chemoradiation in Patients With Low-Risk Nasopharyngeal Cancer
2024 ASCO Breakthrough
August 01, 2024
New Genetic Test May Predict Response to Immunotherapy in Triple-Negative Breast Cancer
2024 European Breast Cancer Conference
August 01, 2024
Glofitamab Combination Therapy Shows Survival Benefit in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
European Hematology Association 2024 Congress
July 18, 2024
New Genetic Test May Predict Response to Immunotherapy in Triple-Negative Breast Cancer
2024 European Breast Cancer Conference
July 01, 2024
Top-line Data on RESTORE Study of Optogenetic Therapy for Retinitis Pigmentosa Presented at ASRS
American Society of Retina Specialists annual meeting
July 01, 2024
Interim Phase 1 HELIOS Trial Data of Axpaxli for NPDR Presented at ASRS
American Society of Retina Specialists annual meeting
July 01, 2024
Supplemental Injection Data From DAVIO 2 Trial of EYP-1901 Presented at ASRS
American Society of Retina Specialists annual meeting
June 25, 2024
Study Documents Decline in Reimbursements for Breast Cancer Surgery From 2003 to 2023
2024 American Society of Breast Surgeons Annual Meeting
June 18, 2024
Can FAP-Targeted Radioligand Therapy Benefit Patients With Advanced Sarcomas?
2024 SNMMI Annual Meeting
June 17, 2024
Chelating Agent May Reduce Toxicity Associated With PSMA Radiopharmaceutical Therapy
2024 SNMMI Annual Meeting
June 17, 2024
Pretargeted Dual-Isotope Radionuclide Therapy in Colorectal Cancer
2024 SNMMI Annual Meeting
June 14, 2024
Innovative Staging System for De Novo Metastatic Breast Cancer Validated Internationally
2024 Society of Surgical Oncology Annual Meeting
June 06, 2024
Study Finds Early Menopause May Be Linked to Greater Risk of Breast and Ovarian Cancers
ENDO 2024
June 05, 2024
Impact of High Blood Insulin Levels on Triple-Negative Breast Cancer Survival in Black Women
ENDO 2024
June 01, 2024
Antibody-Drug Conjugate Plus Checkpoint Inhibitor for PD-L1–Positive, HR-Positive/HER2-Negative Breast Cancer
2024 ASCO Annual Meeting
May 30, 2024
Study Links Abortion Bans to Increased Risk of Pregnancy Violence
American College of Obstetricians and Gynecologists
May 29, 2024
Innovative Staging System for De Novo Metastatic Breast Cancer Validated Internationally
2024 Society of Surgical Oncology Annual Meeting
May 24, 2024
Breast-Conserving Therapy in BRCA-Mutation Carriers: Study Looks at Long-Term Outcomes
2024 Society of Surgical Oncology Annual Meeting
May 24, 2024
NCCN Clinical Practice Guidelines in Oncology: 2024 Updates
2024 NCCN Annual Conference
May 24, 2024
Is a Test for Early Detection of Pancreatic Cancer on the Horizon?
AACR Annual Meeting 2024
May 24, 2024
Novel Approaches Show Early Activity in Endocrine-Resistant Breast Cancer
2024 Miami Breast Cancer Conference
May 22, 2024
Survival Outcomes Following Adjuvant Therapy in Patients With Clinical T2N0 Rectal Adenocarcinoma
Digestive Disease Week 2024
May 17, 2024
Pain & Perception: TikTok's Take on Gynecology Procedures
American College of Obstetricians and Gynecologists
May 13, 2024
Oral Rinse Could Provide Early Screening for Gastric Cancer
Digestive Disease Week 2024
May 13, 2024
Colorectal Cancer Incidence Is Rising Among Teenagers and Young Adults
Digestive Disease Week 2024
May 13, 2024
Beyond Lung Cancer: Leveraging Machine Learning Techniques to Understand Other Diseases
Quantitative Imaging Workshop XX
May 13, 2024
Celebrating Excellence: Matthijs Oudkerk, PhD, MD, MSc, Honored for Contributions to Cancer Prevention and Research
Quantitative Imaging Workshop XX
May 09, 2024
Bispecific Antibody Plus Chemotherapy Improves Survival in Patients With Gastric or Gastroesophageal Junction Cancer
AACR Annual Meeting 2024
May 07, 2024
Novel Urine Biomarker Test May Reduce Unnecessary Cystoscopies in Patients With Bladder Cancer
European Association of Urology Congress 2024
April 25, 2024
Novel MDM2 Inhibitor Shows Activity in Salivary Gland Cancers
2024 Multidisciplinary Head and Neck Cancers Symposium
April 25, 2024
Progression-Free Survival Benefit Confirmed With Triplet Combination in BRCA Wild-Type, HRD-Positive Ovarian Cancer
SGO 2024 Annual Meeting on Womens Cancer
April 22, 2024
Bispecific Immune Checkpoint Inhibitor Improves Survival in Patients With Gastric Cancer, Regardless of PD-L1 Status
AACR Annual Meeting 2024
April 12, 2024
Improving Adjuvant Treatment in Patients With Muscle-Invasive Urothelial Carcinoma
European Association of Urology Congress 2024
April 12, 2024
The Lancet Commission on Prostate Cancer: Strategies to Prepare for Predicted Increases in Disease Burden by 2040
European Association of Urology Congress 2024
April 08, 2024
Undocumented Cost-of-Care Discussions: A Missed Opportunity in Cancer Treatment
2023 ASCO Quality Care Symposium
April 05, 2024
Pembrolizumab May Improve Breast Cancer Outcomes Regardless of Age or Menopausal Status
2024 EBCC
March 22, 2024
Addition of Atezolizumab to Adjuvant Chemotherapy in Triple-Negative Breast Cancer
2024 EBCC
March 19, 2024
ChatGPT May Accurately Answer Common Patient Questions Regarding Gynecologic Cancer
SGO 2024 Annual Meeting on Womens Cancer
March 12, 2024
HPV-Associated Oropharyngeal Cancer: Intratreatment FDG-PET Response as a Biomarker for De-escalation of Radiotherapy
2024 Multidisciplinary Head and Neck Cancers Symposium
March 05, 2024
High-Risk Localized Prostate Cancer: Survival Benefit With Long-Term ADT and Dose-Escalated Radiation Therapy
2024 ASCO GU Cancers Symposium
March 05, 2024
HPV-Associated Oropharyngeal Cancer: Adjuvant Treatment Deintensification
2024 Multidisciplinary Head and Neck Cancers Symposium
March 01, 2024
Guest Editorial: Innovations in Glaucoma Treatment and Diagnosis
ASCRS Annual Meeting
February 28, 2024
Patients With Advanced Breast Cancer May Gain Multiple Benefits From Exercise as Part of Palliative Care
2023 SABCS
February 28, 2024
NATALEE Trial: Long-Term Results on Ribociclib Combination Therapy in Early-Stage Breast Cancer
2023 SABCS
February 16, 2024
Study Examines Real-World Outcomes With Ivosidenib vs Venetoclax in Acute Myeloid Leukemia
2023 ASH
February 15, 2024
Do Patients With Molecular MRD Detected After Colorectal Cancer Surgery Benefit From Adjuvant Chemotherapy?
2024 ASCO GI Cancers Symposium
January 30, 2024
Immune Checkpoint Inhibitor–Based Therapy May Have Comparative Efficacy in Black and White Patients With Metastatic Renal Cell Carcinoma
2024 ASCO GU Cancers Symposium
January 30, 2024
Use of Adjuvant Nivolumab in Patients With Muscle-Invasive Urothelial Carcinoma: CheckMate 274
2024 ASCO GU Cancers Symposium
January 25, 2024
Integrated Medicine and Collaborative Care: Innovations in Cancer Treatment and Mental Health Care
2023 ASCO Quality Care Symposium
January 25, 2024
ALL in Adults: Trial Updates and Clinical Considerations for Selecting Consolidation Therapy
2023 NCCN Annual Congress: Hematologic Malignancies
January 24, 2024
Study Finds Majority of Patients With Lynch Syndrome Are Not Using Aspirin to Reduce Risk of Colon Cancer
2024 ASCO GI Cancers Symposium
January 03, 2024
Phase III Trial Shows Novel Four-Drug Regimen Improves Survival Outcomes in Extensive-Stage Small Cell Lung Cancer
IASLC 2023 WCLC
December 21, 2023
Cardiovascular Health of Women Treated for Cancer: Understanding the Long-Term Risks
2023 Global Cardio-Oncology Summit
December 21, 2023
International Collaborative Research Efforts in Cardio-oncology: Focus on Basic and Translational Science
2023 Global Cardio-Oncology Summit
December 11, 2023
Oncology Care Model: Studies Find Significant Savings but Minor Quality Improvement
2023 ASCO Quality Care Symposium
December 11, 2023
Antibody-Drug Conjugate Makes Progress as Second-Line Therapy for Advanced NSCLC
ESMO Congress 2023
December 11, 2023
Understanding the Treatment Options for PD-1–Refractory Melanoma
2023 Debates and Didactics in Hematology and Oncology Conference
November 30, 2023
First-Line Selpercatinib: New Standard of Care for RET-Positive Medullary Thyroid Cancer?
ESMO Congress 2023
November 27, 2023
KRAS G12C Inhibitors: Durability of Response, Efficacy in Combination, in NSCLC
IASLC 2023 WCLC
November 22, 2023
Adjuvant Everolimus Improves Recurrence-Free Survival in Very High–Risk Renal Cell Carcinoma
ESMO Congress 2023
November 22, 2023
Optimizing Treatment Selection for Newly Diagnosed and Secondary AML: Focus on Cytogenetic and Molecular Data
2023 NCCN Annual Congress: Hematologic Malignancies
November 17, 2023
Extensive-Stage Small Cell Lung Cancer: Triplet Combination vs Chemotherapy Alone
IASLC 2023 WCLC
November 10, 2023
Cardiovascular Disease and Cancer: A Reciprocal Relationship?
2023 Global Cardio-Oncology Summit
October 25, 2023
NATALEE Trial: Quality of Life Maintained for Many Patients Treated With Ribociclib for Early-Stage Breast Cancer
2023 ESMO Virtual Plenary
October 25, 2023
The New Era of Perioperative Therapy in Non–Small Cell Lung Cancer
2023 Debates and Didactics in Hematology and Oncology Conference
October 17, 2023
Overall Survival in Two Monarch Trials of Abemaciclib in Advanced Breast Cancer
ESMO Congress 2022
October 17, 2023
Can Younger Women With Hormone Receptor–Positive Breast Cancer Safely Pause Endocrine Therapy to Pursue Pregnancy?
2022 San Antonio Breast Cancer Symposium
October 17, 2023
SOFT Analysis: Breast Cancer Index May Identify Which Patients Need Ovarian Suppression
2022 San Antonio Breast Cancer Symposium
October 17, 2023
EMERALD Trial: Elacestrant vs Standard Endocrine Monotherapy for Advanced Breast Cancer After CDK4/6 Inhibition
2022 San Antonio Breast Cancer Symposium
October 17, 2023
Should CDK4/6 Inhibitors Be a First-Line Option for Advanced Hormone Receptor–Positive, HER2-Negative Breast Cancer?
2023 ASCO Annual Meeting
October 04, 2023
Using Recent Diagnostic Scans May Cut Time to Treatment for Patients Needing Urgent Palliative Radiotherapy
2023 ASTRO Annual Meeting
October 03, 2023
Stereotactic Radiotherapy for Patients With Primary RCC Unsuitable for Surgery: FASTRACK II
2023 ASTRO Annual Meeting
October 03, 2023
Liquid Biopsies May Be Predictive of Cancer Recurrence Following Chemoradiation in Patients With Cervical Cancer
2023 ASTRO Annual Meeting
September 26, 2023
Understanding the Treatment of Waldenström’s Macroglobulinemia
2023 Debates and Didactics in Hematology and Oncology Conference
September 20, 2023
CLL14: Long-Term Results of Fixed-Duration Venetoclax Plus Obinutuzumab in Elderly Patients With CLL
EHA Hybrid Congress 2023
September 20, 2023
Potential of Quizartinib for Improving Outcomes in Acute Myeloid Leukemia
EHA Hybrid Congress 2023
September 14, 2023
Pembrolizumab Plus Chemoradiation Therapy Falls Short in Locally Advanced Head and Neck Cancer
ESMO Congress 2022
September 14, 2023
Cabozantinib Plus Atezolizumab Warrants Further Study in Treatment of Advanced Head and Neck Cancer
SITC 2022
September 14, 2023
Could Fluorouracil-Free First-Line Regimen Challenge the Standard of Care in Advanced Head and Neck Cancer?
ESMO Congress 2022
September 11, 2023
Expert Point of View: Peter Paul Yu, MD, FACP, FASCO
2023 ASCO Breakthrough Meeting
September 01, 2023
Cardiovascular Disease in Hematologic Malignancies: Who Is at Risk?
2021 ACC Conference on Advancing the Cardiovascular Care of the Oncology Patient
September 01, 2023
Cardiovascular Concerns With the Use of VEGFR Tyrosine Kinase Inhibitors
2021 ACC Conference on Advancing the Cardiovascular Care of the Oncology Patient
August 24, 2023
Liquid Biopsy Assay Demonstrated Effectiveness in Early Cancer Detection in Asymptomatic Individuals in Vietnam
2023 ASCO Breakthrough Meeting
August 24, 2023
Noninvasive, Multitarget Stool DNA Methylation Assay Under Study in Early Detection of Multiple Gastrointestinal Cancers
2023 ASCO Breakthrough Meeting
August 18, 2023
PROpel Trial: Improvement in Progression-Free Survival With First-Line Olaparib Plus Abiraterone in Metastatic Prostate Cancer
2023 ASCO Genitourinary Cancers Symposium
August 17, 2023
CARTITUDE-4: Ciltacabtagene Autoleucel Beneficial in Early Myeloma Relapse
2023 ASCO Annual Meeting
August 17, 2023
ZUMA-7: Primary Overall Survival Analysis Supports Axicabtagene Ciloleucel as Second-Line Therapy in Advanced Lymphoma
2023 ASCO Annual Meeting
July 24, 2023
Two Studies Highlight Benefits in Quality of Life and Symptom Management With Novel Treatments of Advanced Breast Cancer
ESMO Breast Cancer Annual Congress 2023
July 06, 2023
Two Studies of Atezolizumab-Based Regimens in Early-Stage, Triple-Negative and HER2-Positive Breast Cancers
ESMO Breast Cancer Annual Congress 2023
June 23, 2023
In Case You Missed It: Brief Highlights From Studies Presented During AACR 2023
AACR Annual Meeting 2023
June 15, 2023
Novel Hormone Receptor–Driven Therapies Tackling Endocrine Resistance in Breast Cancer
2023 Miami Breast Cancer Conference
June 15, 2023
Surveillance Mammography Rates After Breast Cancer Treatment Remain High, Irrespective of Life Expectancy
24th ASBrS Annual Meeting
June 09, 2023
HER3-Targeting Antibody-Drug Conjugates Show Encouraging Results in Breast Cancer Subtypes
ESMO Breast Cancer Annual Congress 2023
June 07, 2023
Amivantamab Shows Efficacy in Advanced NSCLC With EGFR Exon 20 Insertions
European Lung Cancer Congress 2023
June 07, 2023
CodeBreaK 200: Sotorasib Offers Improved Quality of Life for Patients With Previously Treated NSCLC
European Lung Cancer Congress 2023
May 25, 2023
GOG 258 Final Results: No Improvement in Survival by Adding Radiotherapy to Chemotherapy in Advanced Endometrial Cancer
SGO 2023 Annual Meeting on Women’s Cancer
May 25, 2023
NCCN Clinical Practice Guidelines in Oncology: 2023 Updates
NCCN 2023 Annual Conference
May 19, 2023
NCCN Clinical Practice Guidelines in Oncology: 2023 Updates
NCCN 2023 Annual Conference
May 11, 2023
GOG 3026: Durable Responses With Ribociclib Plus Letrozole in Low-Grade Serous Ovarian Cancer
SGO 2023 Annual Meeting on Women’s Cancer
May 01, 2023
Intraoperative vs Postoperative Lymph Node Pathology Evaluation in Patients With Breast Cancer Undergoing Mastectomy
24th ASBrS Annual Meeting
May 01, 2023
Does Surveillance Mammography Benefit Geriatric Patients With Breast Cancer?
24th ASBrS Annual Meeting
April 25, 2023
Early-Stage Triple-Negative Breast Cancer: Optimizing Therapy
2023 Miami Breast Cancer Conference
April 17, 2023
Single-Agent Pembrolizumab May Benefit Patients With Advanced Desmoplastic Melanoma
AACR Annual Meeting 2023
April 12, 2023
ELCC 2023: New Data on Amivantamab-vmjw in Patients With Advanced NSCLC and EGFR Exon 20 Insertion Mutations
European Lung Cancer Congress 2023
April 07, 2023
Understanding Fertility Issues in Young Patients With Breast Cancer
2023 Miami Breast Cancer Conference
March 29, 2023
Positive Outcomes Demonstrated in Patients With Ovarian Cancer Treated With Olaparib Prior to Surgical Intervention and Subsequent Chemotherapy
SGO 2023 Annual Meeting on Women’s Cancer
March 24, 2023
FORMULA-509: Intensified Postoperative Regimen May Be of Benefit in Subset of High-Risk Prostate Cancer
2023 ASCO Genitourinary Cancers Symposium
March 14, 2023
Novel Urine Test May Play a Role in Bladder Cancer Prediction
2023 EAU Annual Congress
March 14, 2023
New Technique May Reduce Postoperative Complications in Prostate Cancer Surgery
2023 EAU Annual Congress
March 13, 2023
PSMA-PET/CT May Help Improve Clinical Treatment of Prostate Cancer
2023 EAU Annual Congress
March 10, 2023
Abstracts of Interest on Novel Therapies for Gastrointestinal Cancers
2023 ASCO Gastrointestinal Cancers Symposium
February 16, 2023
Blinatumomab Improves Survival in MRD-Negative, B-Cell ALL
2022 ASH Annual Meeting and Exposition
February 16, 2023
Complete Response to Glofitamab at End of Treatment Heralds Prolonged Remission in Lymphoma
2022 ASH Annual Meeting and Exposition
February 13, 2023
Subset of Patients With Advanced Gastric Cancer May Benefit From Claudin18.2-Targeted Agent Zolbetuximab
2023 ASCO Gastrointestinal Cancers Symposium
January 31, 2023
Subset of Patients With Advanced Gastric/GEJ Cancer May Benefit From CLDN18.2-Targeted Drug Zolbetuximab: SPOTLIGHT Study
2023 ASCO Gastrointestinal Cancers Symposium
January 31, 2023
How Experts Treat Mantle Cell Lymphoma in First Complete Response
2022 Pan Pacific Lymphoma Conference
January 25, 2023
Cabozantinib Plus Atezolizumab Warrants Further Study in Treatment of Advanced Head and Neck Cancer
SITC 2022
January 25, 2023
Study Finds Immune Checkpoint Inhibitors Safe and Effective for Patients Living With HIV Who Have NSCLC
SITC 2022
January 25, 2022
AGILE Study: Addition of Ivosidenib to Azacitidine Triples Median Overall Survival in Difficult-to-Treat AML Population
2021 ASH Annual Meeting & Exposition
January 25, 2022
Aggressive Supportive Treatment for COVID-19 May Be Needed in Patients With Hematologic Cancers
2021 ASH Annual Meeting & Exposition
January 25, 2022
PI3K Pathway Activation May Underlie Tamoxifen-Associated Uterine Cancer
2021 San Antonio Breast Cancer Symposium
January 25, 2022
Expert Point of View: Steven J. Isakoff, MD, PhD
2021 San Antonio Breast Cancer Symposium
January 17, 2022
Measurable Residual Disease Kinetics: A Potential New Tool in CLL
2021 ASH Annual Meeting & Exposition
January 04, 2022
Identifying Women With Triple-Negative Breast Cancer Who May Benefit From Pembrolizumab Plus Chemotherapy
2021 San Antonio Breast Cancer Symposium
December 21, 2021
Composite Biomarker Needed to Predict Benefit of Immunotherapy in Triple-Negative Breast Cancer
2021 Lynn Sage Breast Cancer Symposium
December 21, 2021
Novel Vaccine Platform Plus Pembrolizumab May Boost Immune Response in Advanced HCC
SITC 2021
December 20, 2021
Society for Integrative Oncology Focuses on the Science of Living Well With Cancer
2021 Society for Integrative Oncology (SIO) International Conference
December 10, 2021
KEYNOTE-355 Final Analysis Reveals Survival Benefit With Pembrolizumab in Triple-Negative Breast Cancer
ESMO Congress 2021
December 10, 2021
Radiation Therapy for HPV-Related Oropharyngeal Squamous Cell Carcinoma: Prospects and Controversies
2021 Winship Cancer Institute of Emory University Symposium: Updates in the Management of Head and Neck Cancer.
December 10, 2021
Applying Research Data to Clinical Practice in Managing Head and Neck Cancer
2021 Winship Cancer Institute of Emory University Symposium: Updates in the Management of Head and Neck Cancer.
December 10, 2021
Optimizing the Use of Checkpoint Inhibitors in Recurrent or Metastatic Head and Neck Cancer
2021 Winship Cancer Institute of Emory University Symposium: Updates in the Management of Head and Neck Cancer.
November 24, 2021
Fear of Side Effects and Lack of Awareness: Barriers to Greater Use of Risk-Reducing Medications for Breast Cancer
2021 Lynn Sage Breast Cancer Symposium
November 24, 2021
Risk-Reducing Medications for Breast Cancer Are Becoming Safer and More Tolerable
2021 Lynn Sage Breast Cancer Symposium
November 24, 2021
Accelerated Radiation Therapies Move Forward in Early Breast Cancer
2021 ASTRO Annual Meeting
November 24, 2021
No Survival Benefit but Improved Secondary Endpoints With Radiotherapy Plus Androgen Suppression in Intermediate-Risk Prostate Cancer
2021 ASTRO Annual Meeting
November 24, 2021
Use of Genomic Classifier Score May Help to Personalize Therapy for Men With High-Risk Prostate Cancer
2021 ASTRO Annual Meeting
November 24, 2021
Newer Agents on the Horizon for Refractory or Relapsed DLBCL
NCCN 2021 Virtual Congress: Hematologic Malignancies
November 24, 2021
Novel Therapies Under Study in Acute Myeloid Leukemia
NCCN 2021 Virtual Congress: Hematologic Malignancies
November 24, 2021
Numerous Regimens Proposed for Relapsed or Refractory Myeloma
NCCN 2021 Virtual Congress: Hematologic Malignancies
November 19, 2021
Patients With Hematologic Malignancies: How Robust Is Their Immunity to SARS–CoV-2?
ESMO Congress 2021
November 10, 2021
Areej El-Jawahri, MD, on the Significance of Patient-Reported Outcomes in Gastrointestinal Cancers
2021 ASCO Quality Care Symposium
November 10, 2021
Out-of-Pocket Costs on the Rise for the Four Most Common Cancers, Study Finds
2021 ASCO Quality Care Symposium
October 25, 2021
Phase II Trial Finds Atezolizumab of Benefit in Patients With Lung Cancer and Brain Metastases
IASLC 2021 World Conference on Lung Cancer
October 25, 2021
Novel Urine-Based Test Evaluated in Prostate Cancer Detection and Risk Stratification
AUA 2021
October 20, 2021
Lymphoid Malignancies: What’s Next for Antibody-Drug Conjugates?
2021 Pan Pacific Lymphoma Conference
October 20, 2021
Putting Radiotherapy to Best Use With CAR T-Cell Therapy in Lymphoma
2021 Pan Pacific Lymphoma Conference
October 13, 2021
Novel HER2-Targeted Therapies Pose Sequencing Challenges
38th Annual Miami Breast Cancer Conference
October 10, 2021
Expert Point of View: Ichiro Yoshino, MD, PhD
IASLC 2021 World Conference on Lung Cancer
October 10, 2021
Expert Point of View: Charles M. Rudin, MD, PhD
IASLC 2021 World Conference on Lung Cancer
October 10, 2021
Tackling a Growing Need: Options After CAR T-Cell Therapy for Lymphoma
2021 Pan Pacific Lymphoma Conference
September 24, 2021
Outcomes Notably Improving for Adult ALL
2021 Debates and Didactics in Hematology and Oncology
September 24, 2021
Adoptive Cell Therapy May Soon Be Available for Patients With Melanoma
2021 Debates and Didactics in Hematology and Oncology
September 17, 2021
Phase III ARIEL4 Trial Evaluates Rucaparib’s Benefit in BRCA-Mutated Relapsed Ovarian Cancer
SGO 2021 Virtual Annual Meeting on Womens Cancer
September 16, 2021
VISION Trial: Novel PSMA-Targeted Radiotherapy Improves Outcomes in Metastatic Prostate Cancer
2021 ASCO Annual Meeting
September 13, 2021
Eric Deutsch, MD, PhD, Comments on the Averectal and AVANA Trials in Rectal Cancer
ESMO World Congress on Gastrointestinal Cancer 2021
September 10, 2021
Are Triplets Necessary for BRAF-Mutated Melanoma?
2021 Debates and Didactics in Hematology and Oncology
September 10, 2021
Early-Phase Study Rediscovers Potential Alternative to Methadone for Cancer Pain
2021 MASCC/ISOO Annual Meeting
September 10, 2021
Study Finds Evidence-Based Interventions Added to Screening Did Not Improve Cancer Pain
2021 MASCC/ISOO Annual Meeting
September 09, 2021
APACT: 5-Year Overall Survival Data Suggest Improved Outcomes in Pancreatic Cancer With Nab-paclitaxel/Gemcitabine
ESMO World Congress on Gastrointestinal Cancer 2021
August 26, 2021
LEAP-004 Trial Update on Lenvatinib Plus Pembrolizumab After Disease Progression in Metastatic Melanoma
2021 ASCO Annual Meeting
August 16, 2021
Phase III GLOW Trial: Improved Outcomes With First-Line Ibrutinib Plus Venetoclax in Elderly Patients With CLL
EHA 2021 Virtual Congress
August 12, 2021
Novel Antibody-Drug Conjugate Under Study in Refractory DLBCL
EHA 2021 Virtual Congress
August 11, 2021
Expert Point of View: Kei Muro, MD, PhD
ESMO World Congress on Gastrointestinal Cancer 2021
August 10, 2021
KEYNOTE-522: Neoadjuvant Pembrolizumab Improves Event-Free Survival in Triple-Negative Breast Cancer
ESMO Breast Cancer Virtual Congress 2021
July 26, 2021
Evandro de Azambuja, MD, PhD, Discusses the Short-HER Trial
ESMO Breast Cancer Virtual Congress 2021
July 26, 2021
Long-Term Analysis of Short-HER Trial of Adjuvant Trastuzumab
ESMO Breast Cancer Virtual Congress 2021
July 26, 2021
MAIA Update: Overall Survival Benefit Reported With Daratumumab Plus Lenalidomide in Myeloma
EHA 2021 Virtual Congress
July 26, 2021
Impact of COVID-19 on Cancer Treatment and Early Detection: Data-Driven Insights
NCCN Virtual Oncology Policy Summit
July 26, 2021
Road Map to More Equitable Care From the Centers for Medicare and Medicaid Services
NCCN Virtual Oncology Policy Summit
July 12, 2021
Beyond CDK4/6 Inhibitors in Metastatic Breast Cancer: What’s Next?
38th Annual Miami Breast Cancer Conference
June 25, 2021
Survivors of Early-Stage Breast Cancer Face Broad Range of Symptoms and Concerns
22nd ASBrS Annual Meeting
June 25, 2021
Cryoablation in Low-Risk Breast Cancers: Minimally Invasive Procedure With Minimal Risk
22nd ASBrS Annual Meeting
June 11, 2021
Adjuvant Imatinib Therapy Offers Survival Benefit in Patients With Resected GIST, but Team Effort May Be Needed to Reduce Early Discontinuation Rates
SSO 2021 International Conference on Surgical Cancer Care
June 10, 2021
Global Responses to COVID-19 Pandemic–Related Disruptions in Cancer Care
SSO 2021 International Conference on Surgical Cancer Care
June 10, 2021
Expert Point of View: Thomas Herzog, MD
SGO 2021 Virtual Annual Meeting on Womens Cancer
June 10, 2021
New Approaches Needed for Patients With Locoregional Breast Cancer Progression During Neoadjuvant Systemic Therapy
22nd ASBrS Annual Meeting
June 10, 2021
Selected Poster Presentations From the NCCN 2021 Annual Conference
NCCN 2021 Virtual Annual Conference
May 27, 2021
Study Finds Adjuvant Immunotherapy of Benefit to Patients With Stage IIB/C Melanoma
SSO 2021 International Conference on Surgical Cancer Care
May 27, 2021
2021 Genitourinary Cancers Symposium: Advancements in the Care of Older Adults With Prostate Cancer
2021 Genitourinary Cancers Symposium
May 25, 2021
NCCN Clinical Practice Guidelines in Oncology: 2021 Updates
NCCN 2021 Virtual Annual Conference
May 12, 2021
CHRONOS-3: Addition of Copanlisib to Rituximab Extends Progression-Free Survival in Relapsed Indolent NHL
AACR Annual Meeting 2021
May 10, 2021
CheckMate 816: Neoadjuvant Nivolumab Plus Chemotherapy Boosts Pathologic Complete Response in Resectable NSCLC
AACR Annual Meeting 2021
April 27, 2021
5-Year Follow-up of SOLO-1: Sustained Benefit for Maintenance Olaparib in Ovarian Cancer
SGO 2021 Virtual Annual Meeting on Womens Cancer
April 27, 2021
Novel HER2-Targeted Therapies Pose Sequencing Challenges
38th Annual Miami Breast Cancer Conference
April 21, 2021
LuPSMA Outperforms Cabazitaxel for Metastatic Castration-Resistant Prostate Cancer in Phase II Trial
2021 Genitourinary Cancers Symposium
April 21, 2021
EV-301 and EV-201 Trials: Enfortumab Vedotin-ejfv Improves Survival in Metastatic Urothelial Cancer
2021 Genitourinary Cancers Symposium
April 21, 2021
First-Line Nivolumab Plus Cabozantinib Improves Outcomes vs Sunitinib in Advanced Renal Cell Carcinoma
ESMO Virtual Congress 2020
April 21, 2021
Front-Line Avelumab Maintenance Improved Survival Across Subgroups With Advanced Urothelial Carcinoma
ESMO Virtual Congress 2020
April 21, 2021
Expert Point of View: Daniel Y. Heng, MD, MPH, and Toni K. Choueiri, MD
ASCO20 Virtual Scientific Program
April 21, 2021
Adjuvant Atezolizumab Fails to Meet Primary Study Endpoint in High-Risk Bladder Cancer
ASCO20 Virtual Scientific Program
April 21, 2021
Adjuvant vs Neoadjuvant Androgen-Deprivation Therapy With Radiotherapy for Prostate Cancer
2020 ASTRO Annual Meeting
April 20, 2021
ITACA Trial: No Survival Benefit for Tailoring Adjuvant Chemotherapy in NSCLC
IASLC 2020 World Conference on Lung Cancer in Singapore
April 09, 2021
Cardiovascular Risks Associated With Checkpoint Inhibitors and CAR T-Cell Therapy
2021 ACC Conference on Advancing the Cardiovascular Care of the Oncology Patient
March 28, 2021
Two Studies Validate Neoadjuvant Chemotherapy With Short-Course Radiotherapy or Long-Term Chemoradiotherapy in Locally Advanced Rectal Cancer
ASCO20 Virtual Scientific Program
March 28, 2021
Molecular Testing in Metastatic Colorectal Cancer: Understanding How, When, and What to Profile
ASCO20 Virtual Education Program
March 25, 2021
Evidence-Based Strategy for Improving Access to Colorectal Cancer Screening for Diverse Populations
AACR Virtual Meeting: COVID-19 and Cancer 2021
March 25, 2021
Study Reports Little Benefit to Adding Pembrolizumab to Neoadjuvant Therapy for Locally Advanced Rectal Cancer
2021 Gastrointestinal Cancers Symposium
March 10, 2021
Prognostic Tool RSClin Introduced for Early Breast Cancer
2020 San Antonio Breast Cancer Symposium
March 10, 2021
Novel Therapies Under Study in Chronic Myeloid Leukemia
2020 ASH Annual Meeting & Exposition
March 10, 2021
Anti-CD20 Monoclonal Antibodies and Risk of Severe COVID-19 Infection and Death in Patients With Lymphoma
AACR Virtual Meeting: COVID-19 and Cancer 2021
March 10, 2021
Expert Point of View: Ana Maria Lopez, MD
AACR Virtual Meeting: COVID-19 and Cancer 2021
March 10, 2021
Expert Point of View: Roy S. Herbst, MD, PhD, FACP, FASCO, and Shinichi Toyooka, MD
IASLC 2020 World Conference on Lung Cancer in Singapore
February 25, 2021
KEYNOTE-598: No Improvement With Addition of Ipilimumab to Pembrolizumab in NSCLC
IASLC 2020 World Conference on Lung Cancer in Singapore
February 19, 2021
Study Finds Asciminib Safer, More Effective Than Bosutinib in Chronic-Phase CML
2020 ASH Annual Meeting & Exposition
February 18, 2021
ClarIDHy Trial: IDH1 Inhibitor Ivosidenib Benefits Survival in Cholangiocarcinoma
2021 Gastrointestinal Cancers Symposium
February 10, 2021
Severity of Patients’ Symptoms May Be Underrecognized During and After Breast Radiotherapy
2020 San Antonio Breast Cancer Symposium
February 10, 2021
Expert Point of View: Rachna T. Shroff, MD
2021 Gastrointestinal Cancers Symposium
January 25, 2021
A Tale of Two CDK4/6 Inhibitors in Early Breast Cancer
2020 San Antonio Breast Cancer Symposium
July 13, 2020
Charles L. Sawyers, MD, FAACR, Voted AACR Academy President-Elect for 2020–2021
AACR Virtual Annual Meeting 2020 II
January 01, 0001
Expert-Led Workshops Kick Off GSLS 2025 Educational Program
2025 Global Specialty Lens Symposium
January 01, 0001
GSLS Course Explores Advanced Myopia Management Strategies
2025 Global Specialty Lens Symposium